Related references
Note: Only part of the references are listed.HDAC expression and clinical prognosis in human malignancies
Wilko Weichert
CANCER LETTERS (2009)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
Promyelocytic Leukemia Nuclear Bodies Link the DNA Damage Repair Pathway with Hepatitis B Virus Replication: Implications for Hepatitis B Virus Exacerbation during Chemotherapy and Radiotherapy
Yih-Lin Chung et al.
MOLECULAR CANCER RESEARCH (2009)
Predictive Value of Expression and Promoter Hypermethylation of XAF1 in Hepatitis B Virus-Associated Hepatocellular Carcinoma Treated with Transplantation
Feng Zhang et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
Florian R. Fritzsche et al.
BMC CANCER (2008)
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
W. Weichert et al.
BRITISH JOURNAL OF CANCER (2008)
DACT3 is an epigenetic regulator of Wnt/β-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications
Xia Jiang et al.
CANCER CELL (2008)
Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer:: Specific role of class I histone deacetylases in vitro and in vivo
Wilko Weichert et al.
CLINICAL CANCER RESEARCH (2008)
MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation
L. M. Wu et al.
CLINICAL GENETICS (2008)
Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells
David W. Chan et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
HDAC3 overexpression and colon cancer cell proliferation and differentiation
Colleen C. Spurling et al.
MOLECULAR CARCINOGENESIS (2008)
Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer:: a retrospective analysis
Wilko Weichert et al.
LANCET ONCOLOGY (2008)
Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells
Y-G Yoo et al.
ONCOGENE (2008)
Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas
Wilko Weichert et al.
NEOPLASIA (2008)
Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma
Yen-Shen Lu et al.
HEPATOLOGY (2007)
SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib
S. Emanuele et al.
APOPTOSIS (2007)
Deciphering the underlying genetic and epignetic events leading to gastric carcinogenesis
Paraskevi Vogiatzi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549)
Radhakrishnan Vinodhkumar et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2007)
Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma
Tatsuya Rikimaru et al.
ONCOLOGY (2007)
Histone deacetylase 3 (HDAC3) and other class IHDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer
AJ Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Epigenetic therapy of cancer: past, present and future
CB Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Evolving anticancer drug valproic acid: Insights into the mechanism and clinical studies
RA Blaheta et al.
MEDICINAL RESEARCH REVIEWS (2005)
Histone deacetylase-1 and-3 protein expression in human breast cancer:: a tissue microarray analysis
CA Krusche et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357
S Armeanu et al.
JOURNAL OF HEPATOLOGY (2005)
The outcome of liver transplantation in patients with hepatocellular carcinoma in the united states between 1987 and 2001: 5-year survival has improved significantly with time
HY Yoo et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Histone deacetylase inhibitors: Development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers
VM Richon et al.
BLOOD CELLS MOLECULES AND DISEASES (2001)
Primary prevention of hepatocellular carcinoma in developing countries
CP Wild et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2000)
Share Paper
